Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Seroma 4Melanoma 3Postoperative Complications 2Breast Neoplasms 2Vulvar Neoplasms 1Stomach Neoplasms 1Lymphoma, Follicular 1Lymphocele 1Lymphedema 1Hemorrhage 1Carcinoma, Squamous Cell 1Bone Neoplasms 1Anastomotic Leak 1

Interventions

Cisplatin 76Radiotherapy 44Cetuximab 40pembrolizumab 39Paclitaxel 34Carboplatin 33Docetaxel 30Fluorouracil 25Radiotherapy, Intensity-Modulated 23Nivolumab 18Drug Therapy 14Radiation 12Erlotinib Hydrochloride 9cemiplimab 8Magnetic Resonance Spectroscopy 8Blood Specimen Collection 8130-nm albumin-bound paclitaxel 8durvalumab 7atezolizumab 7Cyclophosphamide 7Afatinib 7Surveys and Questionnaires 6Surgical Procedures, Operative 6Panitumumab 6Leucovorin 6Esophagectomy 6Chemoradiotherapy 6fludarabine 5aldesleukin 5Radiosurgery 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × Fibrin Tissue Adhesive × Clear all
NCT00324272 2011-08-11

Post-Operative Drainage Following Lymph Node Dissection

Oxford University Hospitals NHS Trust

Phase 4 Completed
74 enrolled 16 charts
Dermatologic

Carcinoma, Squamous Cell, Melanoma, Seroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡